Cryogenic OGS IPO: Complete Analysis & GMP Update

Cryogenic OGS IPO opens for subscription on 3rd July 2025, offering investors a chance to invest in a niche, technology-driven company in the measurement and filtration equipment segment. This book-building IPO consists of 37.80 lakh equity shares, aggregating to a fresh issue of ₹17.77 crore. The shares will be listed on the BSE SME platform on 10th July 2025, marking the company’s debut in the public market.

With a relatively low valuation, robust profit margins, zero debt, and promising grey market premium trends, Cryogenic OGS IPO has drawn attention from retail and HNI investors. This article provides a comprehensive guide to the IPO, including financial analysis, GMP updates, reservation structure, peer comparison, bidding process, and expert opinions to help investors decide whether to subscribe.


Cryogenic OGS IPO Key Details

Detail Information
IPO Open Date 3rd July 2025
IPO Close Date 7th July 2025
Allotment Date 8th July 2025
Refund Initiation 9th July 2025
Listing Date 10th July 2025
Listing Exchange BSE SME
Face Value ₹10 per share
Price Band ₹44 – ₹47 per share
Issue Size ₹17.77 crore (37,80,000 shares)
Issue Type Book Building IPO
Registrar MUFG Intime India Pvt. Ltd.
Lot Size 3,000 shares
Minimum Retail Investment ₹2,82,000 (2 lots)

Share Reservation Breakdown

Cryogenic OGS IPO follows SEBI’s norms for share allocation under a book-building issue.

Category Shares Offered Reservation (%)
Qualified Institutional Buyers (QIBs) 17,91,000 47.38%
Retail Investors 12,60,000 33.33%
Non-Institutional Investors (HNIs) 5,40,000 14.29%
Total 37,80,000 100%

GMP (Grey Market Premium) and Listing Outlook

Grey Market Premium (GMP) acts as an unofficial indicator of expected listing gains. As of 2nd July 2025, the GMP stands at ₹20, implying a possible listing price of ₹67 (₹47 + ₹20), reflecting an estimated 42.55% gain.

Date GMP IPO Price Estimated Listing Price Gain %
02 July 2025 ₹20 ₹47 ₹67 42.55%
01 July 2025 ₹0 ₹47 ₹47 0.00%
26-30 June 2025 ₹0 ₹47 ₹47 0.00%

Note: GMP is not an official metric and should be used cautiously. It is sensitive to market sentiment and external factors.


Financial Overview of Cryogenic OGS Limited

The financial track record of Cryogenic OGS Limited supports its IPO plans. The company has shown consistent growth in revenue and profit after tax over the past three fiscal years.

Summary of Financials (₹ in crore)

Metric FY 2023 FY 2024 FY 2025
Revenue 22.71 25.67 33.79
Profit After Tax (PAT) 4.08 5.35 6.12
Assets 24.00 28.35 33.85
Net Worth 17.52 22.86 28.99
Debt 0.00 0.00 0.00

The company’s zero-debt status, rising net worth, and strong PAT growth make it an attractive SME investment.


Key Financial Ratios

Indicator Pre-IPO Post-IPO
PE Ratio 8.06 10.96
EPS ₹5.83 ₹4.29
Return on Net Worth (RoNW) 21.12% NA
Return on Equity (ROE) 23.62% NA
Return on Capital Employed (ROCE) 28.93% NA
PAT Margin 18.61% NA
EBITDA Margin 24.20% NA
Market Cap (Post IPO) ₹67.12 crore

The company boasts strong profitability metrics and a PE ratio suggesting reasonable valuation compared to its peers.


Peer Comparison

Company Revenue (₹ cr) PE Ratio EPS RoNW (%)
Cryogenic OGS 33.79 8.06 5.83 21.12
Loyal Equipments 71.15 26.21 8.42 20.96

Cryogenic OGS Limited holds a lower PE ratio and competitive RoNW, indicating strong profitability potential in its niche segment.


About the Company: Cryogenic OGS Limited

Founded in 1997, Cryogenic OGS Limited specializes in the design, manufacturing, and assembly of measurement and filtration equipment for industries such as oil and gas, chemicals, and other fluid systems.

Product Portfolio

  • Air Eliminators – Remove gases to improve accuracy in liquid systems

  • Basket Strainers – Filter debris to protect downstream equipment

  • Prover Tanks – Calibrate flow meters for precise measurements

  • Truck Loading Skids – Manage gas and liquid loading with accuracy

  • Additive Dosing Skids – Automate additive dosing with precision

Strengths

  • Unique product technology and niche solutions

  • Zero debt and strong capital structure

  • Experienced promoters and professional team

  • Long-standing supplier and customer relationships

  • Consistent focus on quality assurance and service


Promoter Holdings

Detail Percentage
Pre-Issue Holding 100.00%
Post-Issue Holding To be updated

Promoters Mr. Nilesh Natvarlal Patel, Mrs. Kiranben Nileshbhai Patel, and Mr. Dhairya Patel are expected to retain significant control post-listing.


Objectives of the IPO

Despite earlier confusion in some sources, the Cryogenic OGS IPO is a fresh issue. The company plans to use the proceeds for:

  • Working capital augmentation

  • Expansion of manufacturing facilities

  • Product development

  • General corporate purposes

No part of the funds is directed toward debt repayment due to the company’s zero-debt status.


IPO Lot Size and Investment Details

Investor Type Minimum Lots Shares Investment Amount
Retail 2 6,000 ₹2,82,000
HNI 3 9,000 ₹4,23,000

Applicants can bid for a minimum of 2 lots (6,000 shares) at the upper price band.


How to Apply for the Cryogenic OGS IPO

  1. Research IPO data including GMP, subscription trends, and financials

  2. Open a demat account or use an existing one through platforms like Univest

  3. Log in to your broker’s IPO section and select “Cryogenic OGS IPO”

  4. Enter the bid details and approve the UPI mandate

  5. Track the IPO subscription updates on BSE or NSE

Note: Applying via multiple demat accounts may improve allotment chances, but ensure compliance with SEBI regulations.


How to Check IPO Allotment Status

After the allotment date (8th July 2025), follow these steps:

Through NSE

  • Visit www.nseindia.com

  • Go to IPO allotment section

  • Enter PAN or application number

  • View status

Through Registrar MUFG Intime India Pvt. Ltd.


Expert Review: Should You Subscribe?

According to IPO analyst Dilip Davda (Chittorgarh):

“COL is engaged in high-quality measurement and filtration equipment and systems for various sectors. It posted growth in its top and bottom lines for the reported periods. The company has bright prospects ahead as the sectors it is serving are poised for a fast forward mode. Based on recent financial data, the issue appears reasonably priced. Investors may park funds for medium to long term.”


Pros and Cons of Cryogenic OGS IPO

Pros

  • Low PE valuation

  • Strong margins and zero debt

  • Niche product segment with high demand

  • Consistent financial growth

Cons

  • Low market capitalisation may affect liquidity

  • SME listing comes with regulatory and volatility risks


Final Thoughts

The Cryogenic OGS IPO presents a promising opportunity in the industrial engineering and filtration segment. With strong margins, low valuation, debt-free status, and GMP indicating listing gains, it fits well into the portfolio of investors looking for SME exposure with medium-to-long-term growth potential.

However, due diligence is essential. Carefully consider your investment horizon, risk appetite, and liquidity preferences before subscribing.

ALSO READ: White Force IPO: Full Details, GMP & Investment Guide

Leave a Reply

Your email address will not be published. Required fields are marked *